(Press-News.org) Millions of people with type 1 diabetes depend on daily insulin injections to survive. They would die without the shots because their immune system attacks the very insulin-producing cells it was designed to protect. Now, a University of Missouri scientist has discovered that this attack causes more damage than scientists realized. The revelation is leading to a potential cure that combines adult stem cells with a promising new drug.
The discovery is reported in the current online issue of Diabetes, the American Diabetes Association's flagship research publication. Habib Zaghouani, PhD, J. Lavenia Edwards Chair in Pediatrics, leads the research with his team at the MU School of Medicine.
"We discovered that type 1 diabetes destroys not only insulin-producing cells but also blood vessels that support them," Zaghouani said. "When we realized how important the blood vessels were to insulin production, we developed a cure that combines a drug we created with adult stem cells from bone marrow. The drug stops the immune system attack, and the stem cells generate new blood vessels that help insulin-producing cells to multiply and thrive."
Surrounded by an army of students and a colony of mice, Zaghouani has spent the past 12 years in his lab at MU studying autoimmune diseases like type 1 diabetes. Often called juvenile diabetes, the disease can lead to numerous complications, including cardiovascular disease, kidney damage, nerve damage, osteoporosis and blindness.
Type 1 diabetes attacks the pancreas. The organ, which is about the size of a hand and located in the abdomen, houses cell clusters called islets. Islets contain beta cells that make insulin, which controls blood sugar levels. In people with type 1 diabetes, beta cells no longer make insulin because the body's immune system has attacked and destroyed them.
When the immune system strikes the beta cells, the attack causes collateral damage to capillaries that carry blood to and from the islets. The damage done to the tiny blood vessels led Zaghouani on a new path toward a cure.
In previous studies, Zaghouani and his team developed a drug against type 1 diabetes called Ig-GAD2. They found that treatment with the drug stopped the immune system from attacking beta cells, but too few beta cells survived the attack to reverse the disease. In his latest study, Zaghouani used Ig-GAD2 and then injected adult stem cells from bone marrow into the pancreas in the hope that the stem cells would evolve into beta cells.
"The combination of Ig-GAD2 and bone marrow cells did result in production of new beta cells, but not in the way we expected," Zaghouani said. "We thought the bone marrow cells would evolve directly into beta cells. Instead, the bone marrow cells led to growth of new blood vessels, and it was the blood vessels that facilitated reproduction of new beta cells. In other words, we discovered that to cure type 1 diabetes, we need to repair the blood vessels that allow the subject's beta cells to grow and distribute insulin throughout the body."
Zaghouani is pursuing a patent for his promising treatment and hopes to translate his discovery from use in mice to humans. He is continuing his research with funding from the National Institutes of Health and MU.
"This is extremely exciting for our research team," he said. "Our discovery about the importance of restoring blood vessels has the potential to be applied not only to type 1 diabetes but also a number of other autoimmune diseases."
INFORMATION:
Adult stem cells could hold key to curing Type 1 diabetes
Combining cells from bone marrow with new drug restores insulin production
2013-05-30
ELSE PRESS RELEASES FROM THIS DATE:
Science news from Harvard Stem Cell Institute
2013-05-30
May brought a major advancement in the science of aging when two Harvard Stem Cell Institute (HSCI) researchers announced their discovery of a protein circulating in the blood of mice and humans that shows potential to be a treatment for age-related heart failure. The protein, called GDF-11, reduced the size and thickness of the heart walls when injected into old mice.
There are hundreds of investigators in the HSCI network solving different problems related to cell biology and illness. This month, we feature recently published work by three laboratories on: a therapy ...
Higher-dose RT results in inferior survival in patients with stage III lung cancer
2013-05-30
In a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group (RTOG), high-dose (HD), compared with standard-dose (SD), radiotherapy (RT) with concurrent chemotherapy (CT) did not improve overall survival of patients with stage III non-small-cell lung cancer (NSCLC).
Philadelphia, PA—Of all the patients in the US with lung cancer, the country's leading cause of cancer death, 75 to 80 percent of them have NSCLC, with 30 to 40 percent of those being considered locally advanced (stage IIIA or IIIB). Although RT plus CT has been the standard ...
Stanford scientists develop high-efficiency zinc-air battery
2013-05-30
Stanford University scientists have developed an advanced zinc-air battery with higher catalytic activity and durability than similar batteries made with costly platinum and iridium catalysts. The results, published in the May 7 online edition of the journal Nature Communications, could lead to the development of a low-cost alternative to conventional lithium-ion batteries widely used today.
"There have been increasing demands for high-performance, inexpensive and safe batteries for portable electronics, electric vehicles and other energy storage applications," said Hongjie ...
Organic polymers show sunny potential
2013-05-30
A new version of solar cells created by laboratories at Rice and Pennsylvania State universities could open the door to research on a new class of solar energy devices.
The photovoltaic devices created in a project led by Rice chemical engineer Rafael Verduzco and Penn State chemical engineer Enrique Gomez are based on block copolymers, self-assembling organic materials that arrange themselves into distinct layers. They easily outperform other cells with polymer compounds as active elements.
The discovery is detailed online in the American Chemical Society journal Nano ...
Californians with 'medical home' more likely to get flu shots, preventive treatment
2013-05-30
Too many cooks may spoil a recipe, and too many doctors may give you the flu.
That's the takeaway from a new study by the UCLA Center for Health Policy Research that found that Californians who jump from provider to provider rather than seeing a regular doctor who coordinates their care may be less likely to get the kind of preventive treatment that protects against the flu and flare ups in their chronic conditions.
Specifically, the study used data from the 2009 California Health Interview Survey (CHIS) to estimate whether the approximately 4.76 million California ...
Task master: Categorizing rewards improves motivation
2013-05-30
What truly inspires individuals to perform at their very best? When it comes to motivating others and ourselves, it turns out offering rewards in defined categories, even when they are largely meaningless, can heighten motivation. According to recent research co-authored by Scott S. Wiltermuth, assistant professor of management and organization at USC's Marshall School of Business, even if the rewards are the similar – and the categories arbitrary – the very act of segmenting rewards motivates people to perform better and longer, even on menial tasks.
Wiltermuth's study, ...
Living in poor area as teen could increase risk for chlamydia in young adulthood
2013-05-30
COLUMBUS, Ohio – Living in a poor neighborhood as an adolescent is linked to an increased risk of getting the sexually transmitted infection (STI) chlamydia in young adulthood, according to new research.
Ohio State University researchers analyzed data from a large national study that tracked youths over time. The analysis suggested that children who lived in poor neighborhoods during their teenage years had an almost 25 percent greater risk of having chlamydia in their early 20s – even if they themselves weren't poor – than did teenagers living in wealthier settings.
The ...
From trauma to tau
2013-05-30
University of Texas Medical Branch at Galveston researchers have uncovered what may be a key molecular mechanism behind the lasting damage done by traumatic brain injury.
The discovery centers on a particular form of a protein that neuroscientists call tau, which has also been associated with Alzheimer's disease and other neurodegenerative conditions. Under ordinary conditions, tau is essential to neuron health, but in Alzheimer's the protein aggregates into two abnormal forms: so-called "neurofibrillary tangles," and collections of two, three, or four or more tau units ...
NASA's Swift reveals new phenomenon in a neutron star
2013-05-30
Astronomers using NASA's Swift X-ray Telescope have observed a spinning neutron star suddenly slowing down, yielding clues they can use to understand these extremely dense objects.
A neutron star is the crushed core of a massive star that ran out of fuel, collapsed under its own weight, and exploded as a supernova. A neutron star can spin as fast as 43,000 times per minute and boast a magnetic field a trillion times stronger than Earth's. Matter within a neutron star is so dense a teaspoonful would weigh about a billion tons on Earth.
This neutron star, 1E 2259+586, ...
Artificial sweeteners may do more than sweeten
2013-05-30
AUDIO:
Artificial sweeteners are thought to make foods and drinks taste sweet without any of the other consequences that come from sugar. But now studying people who are obese, nutrition researchers...
Click here for more information.
Researchers at Washington University School of Medicine in St. Louis have found that a popular artificial sweetener can modify how the body handles sugar.
In a small study, the researchers analyzed the sweetener sucralose (Splenda®) in 17 ...
LAST 30 PRESS RELEASES:
Symptoms of long-COVID can last up to two years after infection with COVID-19
Violence is forcing women in Northern Ireland into homelessness, finds new report
Latin American intensivists denounce economic and cultural inequities in the global scientific publishing system
Older adults might be more resistant to bird flu infections than children, Penn research finds
Dramatic increase in research funding needed to counter productivity slowdown in farming
How chemistry and force etch mysterious spiral patterns on solid surfaces
Unraveling the mysteries of polycystic kidney disease
Mother’s high-fat diet can cause liver stress in fetus, study shows
Weighing in on a Mars water debate
Researchers ‘seq’ and find a way to make pig retinal cells to advance eye treatments
Re-purposed FDA-approved drug could help treat high-grade glioma
Understanding gamma rays in our universe through StarBurst
Study highlights noninvasive hearing aid
NASA taps UTA to shape future of autonomous aviation
Mutations disrupt touch-based learning, study finds
Misha lived in zoos, but the elephant’s tooth enamel helps reconstruct wildlife migrations
Eat better, breathe easier? Research points to link between diet, lung cancer
Mesozoic mammals had uniform dark fur
Wartime destruction of Kakhovka Dam in Ukraine has long-term environmental consequences
NIH’s flat 15% funding policy is misguided and damaging
AI reveals new insights into the flow of Antarctic ice
Scientists solve decades-long Parkinson’s mystery
Spinning, twisted light could power next-generation electronics
A planetary boundary for geological resources: Limits of regional water availability
Astronomy’s dirty window to space
New study reveals young, active patients who have total knee replacements are unlikely to need revision surgery in their lifetime
Thinking outside the box: Uncovering a novel approach to brainwave monitoring
Combination immunotherapy before surgery may increase survival in people with head and neck cancer
MIT engineers turn skin cells directly into neurons for cell therapy
High sugar-sweetened beverage intake and oral cavity cancer in smoking and nonsmoking women
[Press-News.org] Adult stem cells could hold key to curing Type 1 diabetesCombining cells from bone marrow with new drug restores insulin production